rdf:type |
|
lifeskim:mentions |
umls-concept:C0002210,
umls-concept:C0031268,
umls-concept:C0032743,
umls-concept:C0046056,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0229671,
umls-concept:C0702240,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C1948041,
umls-concept:C2697585
|
pubmed:issue |
93
|
pubmed:dateCreated |
2009-9-17
|
pubmed:abstractText |
The goal of this study was to assess the clinical usefulness of 18F-FDG PET/ CT for investigating unexplained serum AFP elevation following interventional therapy such as transarterial chemoembolization (TAE) or radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1111-6
|
pubmed:meshHeading |
pubmed-meshheading:19760952-Adult,
pubmed-meshheading:19760952-Aged,
pubmed-meshheading:19760952-Carcinoma, Hepatocellular,
pubmed-meshheading:19760952-Catheter Ablation,
pubmed-meshheading:19760952-Chemoembolization, Therapeutic,
pubmed-meshheading:19760952-Female,
pubmed-meshheading:19760952-Fluorodeoxyglucose F18,
pubmed-meshheading:19760952-Humans,
pubmed-meshheading:19760952-Liver Neoplasms,
pubmed-meshheading:19760952-Male,
pubmed-meshheading:19760952-Middle Aged,
pubmed-meshheading:19760952-Neoplasm Recurrence, Local,
pubmed-meshheading:19760952-Predictive Value of Tests,
pubmed-meshheading:19760952-Radiopharmaceuticals,
pubmed-meshheading:19760952-Retrospective Studies,
pubmed-meshheading:19760952-Sensitivity and Specificity,
pubmed-meshheading:19760952-Tomography, Emission-Computed,
pubmed-meshheading:19760952-Tomography, X-Ray Computed,
pubmed-meshheading:19760952-Tumor Markers, Biological,
pubmed-meshheading:19760952-alpha-Fetoproteins
|
pubmed:articleTitle |
The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
|
pubmed:affiliation |
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
|
pubmed:publicationType |
Journal Article
|